UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Skandinaviska Enskilda Banken AB publ

Skandinaviska Enskilda Banken AB publ lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 516,372 shares of the healthcare conglomerate’s stock after selling 1,428 shares during the period. UnitedHealth Group accounts for approximately 1.2% of Skandinaviska Enskilda Banken AB publ’s holdings, making the stock its 13th biggest position. Skandinaviska Enskilda Banken AB publ owned 0.06% of UnitedHealth Group worth $262,214,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at about $25,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. Promus Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at $32,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the third quarter worth $37,000. Finally, Pillar Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $40,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of several research analyst reports. KeyCorp reissued an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Oppenheimer boosted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Finally, Stephens raised their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Stock Down 1.0 %

NYSE:UNH opened at $481.18 on Thursday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The business’s fifty day moving average price is $512.33 and its 200 day moving average price is $551.50. The firm has a market capitalization of $440.14 billion, a price-to-earnings ratio of 31.04, a PEG ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the business earned $5.83 EPS. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be issued a $2.10 dividend. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.75%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.